Tag: Clearmind Medicine - Page 5 - Psychedelic Alpha

Read more about the article Clearmind Medicine Featured in “Psychedelics Tonight,” Streaming on ALTRD.TV

Clearmind Medicine Featured in “Psychedelics Tonight,” Streaming on ALTRD.TV

Post published:October 11, 2022
Post category:Press Release

Read more about the article Clearmind Announces Notice of Proposed Stock Consolidation

Clearmind Announces Notice of Proposed Stock Consolidation

Post published:September 26, 2022
Post category:Press Release

Read more about the article Clearmind Applies for Patent to Treat Obesity and Metabolic Syndrome

Clearmind Applies for Patent to Treat Obesity and Metabolic Syndrome

Post published:September 23, 2022
Post category:Press Release

Read more about the article Clearmind Medicine Announces Share-Based Payment for one of the Company’s Consultants

Clearmind Medicine Announces Share-Based Payment for one of the Company’s Consultants

Post published:September 18, 2022
Post category:Press Release

Read more about the article Clearmind Medicine Announces Additional Positive Pre-Clinical Results for its Cocaine Addiction Treatment

Clearmind Medicine Announces Additional Positive Pre-Clinical Results for its Cocaine Addiction Treatment

Post published:August 24, 2022
Post category:Press Release

Read more about the article Yale’s Department of Psychiatry Chair to Join Clearmind Medicine

Yale’s Department of Psychiatry Chair to Join Clearmind Medicine

Post published:June 21, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.